Skip to content

Cue Biopharma, Inc.

CUE Nasdaq SEC CIK 1645460

Follow Cue Biopharma Weekly email: filings, results, news

News

3 stories filed under Cue Biopharma, grouped into ongoing threads

Sells

Thread · 2 stories

Cue Biopharma legal chief sells $265,627 in common stock

Markets 37 d ago

Cue Biopharma CEO Lin sells shares worth $1.6 million

Markets 41 d ago 2 sources

More coverage

Cue Biopharma, Inc. (CUE) Discusses Positive Phase II Top Line Results for CUE-221 in Chronic Spontaneous Urticaria - Slideshow

Markets 2 h ago

Profile

Headquarters: BOSTON, MA, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Latest filings

Q2 2026 report10-Q · 14 Aug 2026

Peers

Where this page comes from

Profile · SEC EDGAR

Financials · SEC EDGAR filing dates

News · 3 stories clustered from the RSS aggregator